GeoVax Labs, Inc. (GOVX)
0.206
-0.01
(-3.15%)
USD |
NASDAQ |
Oct 23, 16:00
0.2035
0.00 (0.00%)
After-Hours: 20:00
GeoVax Labs Enterprise Value : -1.302M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -1.302M |
| October 22, 2026 | -1.253M |
| October 21, 2026 | -1.109M |
| October 20, 2026 | -1.147M |
| October 19, 2026 | -1.144M |
| October 16, 2026 | -1.064M |
| October 15, 2026 | -0.9205M |
| October 14, 2026 | -1.042M |
| October 13, 2026 | -0.863M |
| October 12, 2026 | -0.74M |
| October 09, 2026 | -0.7496M |
| October 08, 2026 | -0.7083M |
| October 07, 2026 | -0.6877M |
| October 06, 2026 | -0.6943M |
| October 05, 2026 | -0.4629M |
| October 02, 2026 | -0.4614M |
| October 01, 2026 | -0.4459M |
| September 30, 2026 | -0.3583M |
| September 29, 2026 | -0.2263M |
| September 28, 2026 | -0.2728M |
| September 25, 2026 | -0.2337M |
| September 24, 2026 | -0.1652M |
| September 23, 2026 | -0.0347M |
| September 22, 2026 | -0.1431M |
| September 21, 2026 | -0.177M |
| Date | Value |
|---|---|
| September 18, 2026 | -0.1902M |
| September 17, 2026 | 0.0021M |
| September 16, 2026 | 0.1657M |
| September 15, 2026 | 0.2637M |
| September 14, 2026 | 0.3499M |
| September 11, 2026 | 0.5916M |
| September 10, 2026 | 0.6101M |
| September 09, 2026 | 0.6344M |
| September 08, 2026 | 0.6285M |
| September 04, 2026 | 0.7398M |
| September 03, 2026 | 0.9144M |
| September 02, 2026 | 1.251M |
| September 01, 2026 | 1.642M |
| August 31, 2026 | 1.84M |
| August 28, 2026 | 2.493M |
| August 27, 2026 | 2.463M |
| August 26, 2026 | 1.823M |
| August 25, 2026 | 1.91M |
| August 24, 2026 | 2.237M |
| August 21, 2026 | 1.937M |
| August 20, 2026 | 1.616M |
| August 19, 2026 | 1.562M |
| August 18, 2026 | 1.973M |
| August 17, 2026 | 2.006M |
| August 14, 2026 | 2.471M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 534.42M |
| Amgen, Inc. | 280.78B |
| Anika Therapeutics, Inc. | 273.50M |
| BioCryst Pharmaceuticals, Inc. | 2.436B |
| Imunon, Inc. | 6.743M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.427M |
| Total Expenses (Quarterly) | 4.427M |
| EPS Diluted (Quarterly) | -0.9696 |
| Earnings Yield | -6.76K% |
| Normalized Earnings Yield | -6760.97 |